Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis (HERICA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Grupo de Estudo da Doença Inflamatória Intestinal
ClinicalTrials.gov Identifier:
NCT01408810
First received: July 20, 2011
Last updated: December 17, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)